طب سنتے
➲➲ #ڪپےڪردن مطالب،بدون ذڪر نام ڪانال
شرعا #حرام است و پیگرد اخروےدارد ➲➲
قُــــرْآטּ כرْمــٰانــِے﴿طب سنتے﴾
tg-me.com/q_darmani
قُــــرْآטּ כرْمــٰانــِے﴿طب سنتے﴾ Telegram | DID YOU KNOW?
Telegram is riding high, adding tens of million of users this year. Now the bill is coming due.Telegram is one of the few significant social-media challengers to Facebook Inc., FB -1.90% on a trajectory toward one billion users active each month by the end of 2022, up from roughly 550 million today.
However, analysts are positive on the stock now. “We have seen a huge downside movement in the stock due to the central electricity regulatory commission’s (CERC) order that seems to be negative from 2014-15 onwards but we cannot take a linear negative view on the stock and further downside movement on the stock is unlikely. Currently stock is underpriced. Investors can bet on it for a longer horizon," said Vivek Gupta, director research at CapitalVia Global Research.
قُــــرْآטּ כرْمــٰانــِے﴿طب سنتے﴾ from VNUSA US telegram Group & telegram Channel 10
Telegram قُــــرْآטּ כرْمــٰانــِے﴿طب سنتے﴾
Created:
From: USA and Singapore
Telegram قُــــرْآטּ כرْمــٰانــِے﴿طب سنتے﴾, 283879 Telegram Group & Telegram Channel USA, USTelegram قُــــرْآטּ כرْمــٰانــِے﴿طب سنتے﴾, 283879 Telegram Group & Telegram Channel, Singapore, SG
TG قُــــرْآטּ כرْمــٰانــِے﴿طب سنتے﴾
https://t.me/q_darmani